Tyler S Williamson
Overview
Explore the profile of Tyler S Williamson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The centre for health informatics: a novel approach to accelerating the field of health data science
Southern D, Eastwood C, OConnor E, Doktorchik C, Tonelli M, Meddings J, et al.
Int J Popul Data Sci
. 2024 Dec;
9(1):2368.
PMID: 39620123
Precision Medicine and Precision Public Health are approaches to improve population health. Achieving these goals requires innovation in health informatics. The Centre for Health Informatics (CHI) within the Cumming School...
2.
Black J, Campbell D, Ronksley P, McBrien K, Williamson T
Can J Diabetes
. 2024 Aug;
48(8):487-492.e3.
PMID: 39134119
Objectives: In Canada, regional evaluations of screening practices for chronic kidney disease (CKD) among people with diabetes highlight areas for improvement; however, national estimates are notably absent. Estimates of CKD...
3.
Sandhu N, Whittle S, Southern D, Li B, Youngson E, Bakal J, et al.
Int J Popul Data Sci
. 2024 Feb;
8(4):2160.
PMID: 38419823
Alberta has rich clinical and health services data held under the custodianship of Alberta Health and Alberta Health Services (AHS), which is not only used for clinical and administrative purposes...
4.
Stewart A, Patten S, Fiest K, Williamson T, Wick J, Ronksley P
Health Serv Insights
. 2023 Jun;
16:11786329231183317.
PMID: 37377884
Schizophrenia does not present uniformly among patients and as a result this patient population is characterized by a diversity in the type and amount of healthcare supports needed for daily...
5.
Kinzel M, Kalra A, Khanolkar R, Williamson T, Li N, Khan F, et al.
Transplant Cell Ther
. 2022 Oct;
29(1):43.e1-43.e8.
PMID: 36273783
Rituximab is commonly used as prevention, preemption, or therapeutically for post-transplant lymphoproliferative disorder (PTLD) after hematopoietic cell transplantation (HCT). Although it is generally assumed that rituximab toxicity (ie, infections resulting...
6.
Stewart A, Patten S, Fiest K, Williamson T, Wick J, Ronksley P
Health Promot Chronic Dis Prev Can
. 2022 Oct;
42(10):431-439.
PMID: 36223158
Introduction: Understanding the reasons for the wide variation in health care spending among patients with schizophrenia may benefit the development of interventions aimed at improving patient outcomes and health care...
7.
Black J, Kueper J, Williamson T
Fam Pract
. 2022 Oct;
40(1):200-204.
PMID: 36181463
Classification and prediction tasks are common in health research. With the increasing availability of vast health data repositories (e.g. electronic medical record databases) and advances in computing power, traditional statistical...
8.
Liaw W, Westfall J, Williamson T, Jabbarpour Y, Bazemore A
JMIR Med Inform
. 2022 Mar;
10(3):e27691.
PMID: 35258464
With conversational agents triaging symptoms, cameras aiding diagnoses, and remote sensors monitoring vital signs, the use of artificial intelligence (AI) outside of hospitals has the potential to improve health, according...
9.
Stewart A, Patten S, Fiest K, Williamson T, Wick J, Ronksley P
Can J Psychiatry
. 2022 Mar;
67(9):723-733.
PMID: 35244485
Objectives: Schizophrenia is characterized by high levels of disability often resulting in increased healthcare utilization and spending. With expanding healthcare costs across all healthcare sectors, there is a need to...
10.
Kinzel M, Dowhan M, Kalra A, Williamson T, Dabas R, Jamani K, et al.
Transplant Cell Ther
. 2021 Oct;
28(1):53.e1-53.e10.
PMID: 34607072
Post-transplant lymphoproliferative disorder (PTLD) is a potentially serious complication that occurs following hematopoietic cell transplantation (HCT), in which B cells transformed by Epstein-Barr virus (EBV) proliferate uncontrollably. It is unknown...